AXOVANT SCIENCES LTD's ticker is AXGTXXXX and the CUSIP is G0750W104. A total of 117 filers reported holding AXOVANT SCIENCES LTD in Q2 2017. The put-call ratio across all filers is 0.38 and the average weighting 0.5%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2019 | $602,000 | +109.8% | 452,133 | +56.9% | 0.00% | – |
Q4 2018 | $287,000 | -81.9% | 288,230 | -56.1% | 0.00% | – |
Q3 2018 | $1,589,000 | -14.2% | 656,816 | -19.9% | 0.00% | – |
Q2 2018 | $1,853,000 | +47.6% | 819,574 | -13.2% | 0.00% | – |
Q1 2018 | $1,255,000 | -87.0% | 943,857 | -48.4% | 0.00% | -100.0% |
Q4 2017 | $9,633,000 | -44.1% | 1,827,800 | -27.1% | 0.00% | -50.0% |
Q3 2017 | $17,247,000 | -58.3% | 2,506,800 | +40.7% | 0.01% | -66.7% |
Q2 2017 | $41,327,000 | +328.5% | 1,782,100 | +176.0% | 0.02% | +260.0% |
Q1 2017 | $9,645,000 | +43.2% | 645,584 | +19.0% | 0.01% | +25.0% |
Q4 2016 | $6,734,000 | +0.6% | 542,286 | +13.4% | 0.00% | +33.3% |
Q3 2016 | $6,693,000 | +1024.9% | 478,100 | +930.4% | 0.00% | – |
Q2 2016 | $595,000 | +218.2% | 46,400 | +184.7% | 0.00% | – |
Q1 2016 | $187,000 | -84.5% | 16,300 | -75.7% | 0.00% | – |
Q4 2015 | $1,210,000 | -52.2% | 67,100 | -65.8% | 0.00% | -100.0% |
Q3 2015 | $2,531,000 | +1093.9% | 195,937 | +1784.0% | 0.00% | – |
Q2 2015 | $212,000 | – | 10,400 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
RA Capital Management | 5,000,000 | $57,400,000 | 7.34% |
VHCP Management II, LLC | 429,590 | $4,932,000 | 3.24% |
VHCP Management, LLC | 184,110 | $2,114,000 | 1.84% |
Visium Asset Management, LP | 4,192,769 | $48,132,000 | 0.82% |
Perceptive Advisors | 485,000 | $5,568,000 | 0.49% |
Opus Point Partners Management, LLC | 26,416 | $303,000 | 0.23% |
Virtus ETF Advisers LLC | 12,579 | $144,000 | 0.20% |
BOURGEON CAPITAL MANAGEMENT LLC | 20,700 | $238,000 | 0.16% |
AMERICAN FINANCIAL GROUP INC | 172,395 | $1,980,000 | 0.15% |
NJ State Employees Deferred Compensation Plan | 51,000 | $640,000 | 0.14% |